Chapter 22. Drugs Affecting the Reproductive System
1. Men who use transdermal testosterone gel (&roGel) should be advised to avoid:
1 Washing their h&s after applying the gel
.
2 Wearing occlusive clothing while using the gel
.
3 Exposure to estrogens while using the gel
.
4 Skin-to-skin contact with pregnant women while using the gel
.
2. Education when prescribing androgen to male patients includes advising that:
1 Short-term use places the patient at risk for hepatocellular carcinoma.
.
2 Cholestatic hepatitis & jaundice may occur with low doses of &rogens.
.
3 Gynecomastia is a rare occurrence with the use of &rogens.
.
4 Low sperm levels only occur with long-term use of &rogens.
.
3. Patients who are prescribed exogenous androgens need to be warned that decreased libido:
1 Is an unusual side effect of &rogens & should be reported to the provider
.
2 Is treated with increased doses of &rogens, so the patient should let the provider
. know if he is having problems
3 May be a sign of early prostate cancer & he should make an appointment for a
. prostate screening exam
4 May occur with androgen therapy
.
4. The U.S. Food & Drug Administration warns that androgens may cause:
1 Peliosis hepatis
.
2 Orthostatic hypotension
.
3 Menstrual irregularities
.
4 Acne
.
5. Monitoring for a patient who is using androgens includes evaluation of:
1 Complete blood count & C-reactive protein levels
.
2 Lipid levels & liver function tests
.
3 Serum potassium & magnesium levels
.
4 Urine protein & potassium levels
.
6. Male patients require __ before & during androgen therapy.
1 A digital prostate exam
.
2 A Doppler exam of testicular blood flow
.
3 Urine analysis for proteinuria
.
4 Serial orthostatic blood pressures
This study source was downloaded by 100000847795904 from CourseHero.com on 06-08-2022 00:45:45 GMT -05:00
https://www.coursehero.com/file/113576827/chapter-22-exam-questions-pharmacologydocx/
1. Men who use transdermal testosterone gel (&roGel) should be advised to avoid:
1 Washing their h&s after applying the gel
.
2 Wearing occlusive clothing while using the gel
.
3 Exposure to estrogens while using the gel
.
4 Skin-to-skin contact with pregnant women while using the gel
.
2. Education when prescribing androgen to male patients includes advising that:
1 Short-term use places the patient at risk for hepatocellular carcinoma.
.
2 Cholestatic hepatitis & jaundice may occur with low doses of &rogens.
.
3 Gynecomastia is a rare occurrence with the use of &rogens.
.
4 Low sperm levels only occur with long-term use of &rogens.
.
3. Patients who are prescribed exogenous androgens need to be warned that decreased libido:
1 Is an unusual side effect of &rogens & should be reported to the provider
.
2 Is treated with increased doses of &rogens, so the patient should let the provider
. know if he is having problems
3 May be a sign of early prostate cancer & he should make an appointment for a
. prostate screening exam
4 May occur with androgen therapy
.
4. The U.S. Food & Drug Administration warns that androgens may cause:
1 Peliosis hepatis
.
2 Orthostatic hypotension
.
3 Menstrual irregularities
.
4 Acne
.
5. Monitoring for a patient who is using androgens includes evaluation of:
1 Complete blood count & C-reactive protein levels
.
2 Lipid levels & liver function tests
.
3 Serum potassium & magnesium levels
.
4 Urine protein & potassium levels
.
6. Male patients require __ before & during androgen therapy.
1 A digital prostate exam
.
2 A Doppler exam of testicular blood flow
.
3 Urine analysis for proteinuria
.
4 Serial orthostatic blood pressures
This study source was downloaded by 100000847795904 from CourseHero.com on 06-08-2022 00:45:45 GMT -05:00
https://www.coursehero.com/file/113576827/chapter-22-exam-questions-pharmacologydocx/
